Cytokine antagonists for neurological and neuropsychiatric...

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S422000, C424S427000, C424S434000, C424S134100, C514S885000, C514S886000

Reexamination Certificate

active

06982089

ABSTRACT:
Methods for treating neurological or neuropsychiatric diseases or disorders in humans by administering to the human a therapeutically effective dose of specific biologics are presented. The biologics of consideration include antagonists of tumor necrosis factor or of interleukin-1. The administration of these biologics is performed by specific methods, most, but not all of which fall into the category of anatomically localized administration designed for perispinal use. Anatomically localized administration involving perispinal use includes, but is not limited to the subcutaneous, intramuscular, interspinous, epidural, peridural, parenteral or intrathecal routes. Additonally, intranasal administration is discussed as a method to provide therapeutic benefit. The clinical conditions of consideration include, but are not limited to the following: diseases of the brain, including neurodegenerative diseases such as Alzheimer's Disease and Parkinson's Disease; migraine headache; spinal radiculopathy associated with intervertebral disc herniation, post-herpetic neuralgia, reflex sympathethic dystrophy, neuropathic pain, vertebral disc disease, low back pain, amyotrophic lateral sclerosis, chronic fatigue syndrome; and neuropsychiatric diseases, including bipolar affective disorder, anorexia nervosa, nicotine withdrawal, narcotic addiction, alcohol withdrawl, postpartum depression, and schizoaffective illness.

REFERENCES:
patent: 5075222 (1991-12-01), Hannum et al.
patent: 5574022 (1996-11-01), Roberts et al.
patent: 5605690 (1997-02-01), Jacobs et al.
patent: 5756482 (1998-05-01), Roberts et al.
patent: 5863769 (1999-01-01), Young
patent: 6013253 (2000-01-01), Martin et al.
patent: 6015557 (2000-01-01), Tobinick et al.
patent: 6096728 (2000-08-01), Collins et al.
patent: 6159460 (2000-12-01), Thompson et al.
patent: 6177077 (2001-01-01), Tobinick
patent: 6277969 (2001-08-01), Le et al.
patent: 6406867 (2002-06-01), Yu et al.
patent: 6419934 (2002-07-01), Tobinick
patent: 6419944 (2002-07-01), Tobinick
patent: 6423321 (2002-07-01), Tobinick
patent: 6428787 (2002-08-01), Tobinick
patent: 6471961 (2002-10-01), Tobinick
patent: 6537549 (2003-03-01), Tobinick
Kroin et al. The distribution of medication along the spinal canal after chronic intrathecal administration. Neurosurgery, 1993, vol. 33(2), 226-230.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cytokine antagonists for neurological and neuropsychiatric... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cytokine antagonists for neurological and neuropsychiatric..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytokine antagonists for neurological and neuropsychiatric... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3576676

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.